Cargando…
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
The severe acute respiratory syndrome caused by the new coronavirus (SARS-CoV-2), termed COVID-19, has been highlighted as the most important infectious disease of our time, without a vaccine and treatment available until this moment, with a big impact on health systems worldwide, and with high mort...
Autores principales: | Melgaço, Juliana Gil, Brito e Cunha, Danielle, Azamor, Tamiris, da Silva, Andrea Marques Vieira, Tubarão, Luciana Neves, Gonçalves, Rafael Braga, Monteiro, Robson Q., Missailidis, Sotiris, da Costa Neves, Patricia Cristina, Ano Bom, Ana Paula Dinis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753942/ https://www.ncbi.nlm.nih.gov/pubmed/33426096 http://dx.doi.org/10.1155/2020/8827670 |
Ejemplares similares
-
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
por: de Brito e Cunha, Danielle, et al.
Publicado: (2022) -
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?
por: Melgaço, Juliana Gil, et al.
Publicado: (2020) -
Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case
por: Melgaço, Fabiana Gil, et al.
Publicado: (2021) -
Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-γ and CLEC5A
por: Azamor, Tamiris, et al.
Publicado: (2021) -
Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
por: Dinis Ano Bom, Ana Paula, et al.
Publicado: (2019)